Try it
General Surgery · Breast: adjuvant targeted therapy
Sample itemA 52-year-old woman with HER2-positive breast cancer is to receive adjuvant trastuzumab after anthracycline chemotherapy. Which adverse effect requires baseline and periodic echocardiographic monitoring?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Reduction in left ventricular ejection fraction
Trastuzumab blocks HER2 signalling, which cardiomyocytes need for stress adaptation, and it causes a usually reversible fall in ejection fraction. The risk rises when it follows anthracyclines, so ejection fraction is checked before and during treatment, and the drug is held if it falls significantly.
Option by option
A. Reduction in left ventricular ejection fraction (correct)
Correct. Cardiac dysfunction is the principal dose-independent toxicity of trastuzumab.
B. Sensorineural hearing loss
Ototoxicity is characteristic of cisplatin and aminoglycosides.
C. Haemorrhagic cystitis
Haemorrhagic cystitis is caused by cyclophosphamide and ifosfamide through acrolein.
D. Pulmonary fibrosis
Pulmonary fibrosis is characteristic of bleomycin and busulfan.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Surgery questions
- HerniaA groin hernia that passes medial to the inferior epigastric vessels through Hesselbach'…
- BurnsA 70 kg adult has burns over 40% of the body surface. By the Parkland formula, what tota…
- HerniaA hernia that enters the inguinal canal through the deep ring, lateral to the inferior e…
- Intestinal obstructionWhat is the commonest cause of small bowel obstruction in adults?